title: Allelic variation in the promoter region of the LDL receptor gene: analysis of an African-specific variant in the FP2 cis-acting regulatory element.
abstract: DNA samples of 2303 individuals from nine different population groups were screened for variant -175g-->t in the promoter region of the low-density lipoprotein receptor (LDLR) gene. The -175g-->t variant detected at carrier frequencies of 3-10% in different African population groups was absent in the Caucasian and Asian (Chinese) individuals studied. In contrast to previous findings in Black South Africans where this polymorphism predominated in patients with familial hypercholesterolaemia (FH), it occurred at a significantly lower frequency in hypercholesterolaemics from the recently admixed Coloured population of South Africa compared with population-matched controls (P<0.0001). Haplotype and mutation analysis excluded the likelihood that this finding is due to association with a specific disease-related mutation in FH patients, although reversal of the positive association with FH observed in the Black population may, at least in part, be due to admixture linkage disequilibrium. Transient transfection studies in HepG2 cells demonstrated that the -175t allele is associated with a non-significant decrease ( approximately 7%) of LDLR transcription in the absence of sterols. The data presented in this study raise the possibility that the -175g-->t polymorphism may have subtle effects that become clinically important within certain genetic and/or environmental contexts.
authors.affiliation: Division of Human Genetics, Faculty of Health Sciences, University of Stellenbosch, Tygerberg, South Africa.
authors.forename: C F
authors.initials: CF
authors.lastname: Hoogendijk
authors.forename: C L
authors.initials: CL
authors.lastname: Scholtz
authors.forename: S M
authors.initials: SM
authors.lastname: Pimstone
authors.forename: E
authors.initials: E
authors.lastname: Ehrenborg
authors.forename: J J P
authors.initials: JJ
authors.lastname: Kastelein
authors.forename: J C
authors.initials: JC
authors.lastname: Defesche
authors.forename: R
authors.initials: R
authors.lastname: Thiart
authors.forename: L
authors.initials: L
authors.lastname: du Plessis
authors.forename: J N P
authors.initials: JN
authors.lastname: de Villiers
authors.forename: M G
authors.initials: MG
authors.lastname: Zaahl
authors.forename: R
authors.initials: R
authors.lastname: Delport
authors.forename: D C
authors.initials: DC
authors.lastname: Rubinsztein
authors.forename: L J
authors.initials: LJ
authors.lastname: Raffel
authors.forename: C E
authors.initials: CE
authors.lastname: Grim
authors.forename: S
authors.initials: S
authors.lastname: Mediene-Benchekor
authors.forename: P
authors.initials: P
authors.lastname: Amouyel
authors.forename: T
authors.initials: T
authors.lastname: Brousseau
authors.forename: K
authors.initials: K
authors.lastname: Steyn
authors.forename: C J
authors.initials: CJ
authors.lastname: Lombard
authors.forename: M R
authors.initials: MR
authors.lastname: Hayden
authors.forename: M J
authors.initials: MJ
authors.lastname: Kotze
mesh_terms: D000483:Alleles; D044466:Asian People / Q000235:genetics; D044383:Black People / Q000235:genetics; D004252:DNA Mutational Analysis / Q000379:methods; D005006:Ethnicity; D005787:Gene Frequency; D014644:Genetic Variation; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000453:epidemiology / Q000235:genetics*; D017354:Point Mutation; D011110:Polymorphism, Genetic; D018807:Polymorphism, Single-Stranded Conformational; D011401:Promoter Regions, Genetic; D011973:Receptors, LDL / Q000235:genetics*; D044465:White People / Q000235:genetics
chemical_list: D011973:Receptors, LDL